• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Industrials·JANL
Share

Janel Corporation Stocks

$ 58Last Updated 27.07.2026

Issuer Rating

3/7
Performance

Favourable

Risk

High

Recommendation

Sell

Market Cap

$ 68.81M

$ 58
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Headquartered in New York, NY, Janel Corporation was founded in 1974 and provides a range of services worldwide through its various subsidiaries. The firm adopted its current name in April 2015, previously known as Janel World Trade Ltd. Janel operates across three core business segments: Logistics, Manufacturing, and Life Sciences. The Logistics segment specializes in global cargo movement and supply chain management. This encompasses freight forwarding across air, ocean, and ground modalities, alongside customs brokerage, warehousing, distribution, and supplementary services such as customs filing, cargo insurance procurement, strategic logistics planning, product repackaging, and real-time shipment tracking. Within the Manufacturing division, the company develops and distributes mixing apparatus and equipment catering to diverse industries, including chemicals, inks, paints, construction, plastics, adhesives, cosmetics, food, and pharmaceuticals. Lastly, the Life Sciences segment is dedicated to the production and supply of monoclonal and polyclonal antibodies, diagnostic reagents, and other immunologic reagents crucial for biomedical research. This segment further supports academic and industrial research scientists through antibody manufacturing, and produces items for other life science enterprises on an original equipment manufacturer (OEM) basis.

Company Valuation

Greatly undervalued
7/7

Based on key historical and expected multiples, the stock is greatly undervalued relative to its peers. In particular, the stock is underpriced on P/E, 'cheap' on EV/EBIT

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

30.07.2026 23:45

OpenAI has lowered the price of GPT-5.6 for budget-conscious customers

30.07.2026 23:38

UEFA has threatened to boycott FIFA tournaments over plans to sell World Cup rights to investors

30.07.2026 23:35

The yuan rose to its highest level since 2023 amid a decline in the dollar following the Fed meeting

30.07.2026 22:48

SpaceX has been awarded a $1.6 billion contract by the U.S. Space Force

30.07.2026 22:43

"AI-Nostradamus" sold part of its portfolio due to losses from the tech stock crash

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026